North American prebiotic fiber market poised for major growth
While the Asia-Pacific region is expected to be the fastest-growing, North America remains a key and profitable market.
Thorvardur de Shong
Kroger announces corporate layoffs
The cuts follow Kroger’s decision to close around 60 underperforming stores by 2026.
Lilly’s oral GLP-1 drug nears global filing
Lilly’s oral GLP-1 pill helped patients lose 22 pounds and lower A1C in a Phase 3 trial, with global filings planned this year.
End of an era: Walgreens exits S&P 500
The departure marks the end of Walgreens’ more than decade-long run in the S&P 500 index, reflecting its struggles to adapt to changing healthcare and retail markets.
Taiwan’s WCC Biomedical brings needle-free patch innovation to TSE
This marks the first time WCC Biomedical is presenting at a U.S. trade show.
Improvia brings comfort and dignity to incontinence care
Startup founded by twin brothers grows from caregiving roots to $35 million in sales and prepares for retail expansion, while addressing urgent needs highlighted in AARP’s latest caregiving report.
Rising safety and quality demands fuel expansion of U.S. supplement testing
With the U.S. supplement market continuing to expand, manufacturers are under increasing pressure to substantiate claims.
Express Scripts court case spotlights PBM power
Express Scripts’ court fight with Martella Pharmacies underscores increasing scrutiny of PBMs and concerns over rural pharmacy closures.
Two-thirds of drug production facilities in disaster zones, ACS finds
A new ACS study shows that climate disasters have impacted nearly two-thirds of U.S. drug manufacturing sites, highlighting increasing risks of medication shortages.
AAP guidance breaks with federal policy on COVID-19 vaccination for kids
The pediatric association’s move contrasts with the CDC’s current position, which leaves vaccination decisions for healthy children up to parents and doctors.
Target reports Q2 earnings as sales decline
The retailer reaffirmed its full-year outlook despite investor concerns that sent shares down nearly 9% in early trading.
Canada authorizes Ozempic for kidney and heart protection in diabetes
Health Canada approved Ozempic to slow kidney disease and reduce heart deaths in type 2 diabetes, a first-of-its-kind approval that could help millions.
CRN unveils WellComms 2025 agenda
The event will include sessions on brand protection, influencer partnerships, effective press outreach, and more.
Ulta and Target to end in-store beauty partnership in 2026
Launched in August 2021, the collaboration brought prestige beauty brands to select Target stores and Target.com.
Costco pharmacies to stop offering abortion pill
The decision has drawn praise from religious investors and criticism from abortion rights supporters, as the battle over the pill shifts to CVS and Walgreens.
Aurobindo Pharma to acquire Lannett for $250M
The transaction is subject to regulatory approvals, including clearance from the U.S. Federal Trade Commission, and is expected to close within 8 to 12 months.